AAL(S) was shown to reduce the severity in asthma mice models by suppressing inflammation, mucus-secreting cell numbers, type 2-associated cytokines (IL-33, IL-5 and IL-13), serum IgE and airway hyper-responsiveness [181]. The gene discussed is IL13; the disease is asthma.